Previzion Aksyon REGENXBIO (RGNX)

REGENXBIO

Healthcare · USD · United States of America

Dernie pri$7.38Mizajou 25 Sep 2026 19:59 UTC

Chanjman+1.93%

Previzyon AI: RGNX

1 zour

🔒 Debloke Premium

1 semenn

🔒 Debloke Premium

1 mwa

🔒 Debloke Premium

AI a pibliye yon pri objektif pou pwochen jou trading la, fen semenn nan ak fen mwa nan. Chanjman an mezire depi dènye pri a. Se estimasyon estatistik, se pa konsèy envestisman.

Pri lor dernie 6 mwa

Premium montre bann objektif pri AI pou 1 zour, 1 semenn ek 1 mwa pou sa aksyon la ek pou tou lot aksyon.

Debloke Premium

🔒 Historik previzion

Historik previzion an — chak ansyen previzion bò kote klotir reyèl la — fè pati Premium.

Debloke Premium

Sou Konpayi Sa a

REGENXBIO Inc. is a biotechnology company that specializes in the development, commercialization, and licensing of recombinant adeno-associated virus-based gene therapy technologies.

Aksyon Ki Gen Rapò

TXG10X Genomics Inc Dernie pri$85.71 +1.90%Previzyon AI · 1 zour🔒 Premium

ABTAbbott Dernie pri$101.31 +0.24%Previzyon AI · 1 zour🔒 Premium

ABBVAbbVie Dernie pri$264.31 -0.31%Previzyon AI · 1 zour🔒 Premium

ABCLAbCellera Biologics Dernie pri$12.72 +0.47%Previzyon AI · 1 zour🔒 Premium

ACADACADIA Pharmaceuticals Inc Dernie pri$20.68 -6.76%Previzyon AI · 1 zour🔒 Premium

ACMRACM Research Inc Dernie pri$77.34 +1.52%Previzyon AI · 1 zour🔒 Premium

ADAPAdaptimmune Therapeutics АДР Dernie pri$0.03 +50.00%Previzyon AI · 1 zour🔒 Premium

ADPTAdaptive Biotechnologies Dernie pri$29.45 -0.41%Previzyon AI · 1 zour🔒 Premium

Obtini Previzyon Aksyon AI Aster

Telechaje nou aplikasyon pou previzyon aksyon AI lor iPhone, Android ek Windows

Debloke Premium

Avètisman: Previzyon aksyon ki jenere par AI se pou enfòmasyon sèlman ek pa konstitye konsèy finansye. Rezilta pase pa garanti rezilta futur. Toujou fer ou prop resers ek konsilt yon konseye finansye kalifye avan ou pran desizyon envestisman. Envestisman enplike risk, ki enkli posib pèt kapital.